↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$12KBought on the market
$0.00Sold on the market
1Companies
Sep 2, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 202618:43 | Sep 1, 2026 | ANTXAN2 Therapeutics, Inc. | Director | P · Buy | $5.53 | +2,098 | 10,708 | +24% | +$12K | -11.9% | -15.2% |